162 related articles for article (PubMed ID: 23623930)
1. MicroRNAs in hematological malignancies.
Lawrie CH
Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
[TBL] [Abstract][Full Text] [Related]
2. CircRNAs in hematopoiesis and hematological malignancies.
Bonizzato A; Gaffo E; Te Kronnie G; Bortoluzzi S
Blood Cancer J; 2016 Oct; 6(10):e483. PubMed ID: 27740630
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.
Marques SC; Laursen MB; Bødker JS; Kjeldsen MK; Falgreen S; Schmitz A; Bøgsted M; Johnsen HE; Dybkaer K
Oncotarget; 2015 Jan; 6(1):7-25. PubMed ID: 25622103
[TBL] [Abstract][Full Text] [Related]
4. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.
Huang W; Paul D; Calin GA; Bayraktar R
Cells; 2023 Dec; 13(1):. PubMed ID: 38201290
[TBL] [Abstract][Full Text] [Related]
5. PI3 kinase signaling pathway in hematopoietic cancers: A glance in miRNA's role.
Roshandel E; Noorazar L; Farhadihosseinabadi B; Mehdizadeh M; Kazemi MH; Parkhideh S
J Clin Lab Anal; 2021 Apr; 35(4):e23725. PubMed ID: 33675064
[TBL] [Abstract][Full Text] [Related]
6. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
7. The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.
Pitea M; Canale FA; Porto G; Verduci C; Utano G; Policastro G; Alati C; Santoro L; Imbalzano L; Martino M
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761936
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
[TBL] [Abstract][Full Text] [Related]
9. A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Díaz Méndez AB; Sacconi A; Tremante E; Lulli V; Caprara V; Rosanò L; Goeman F; Carosi M; Di Giuliani M; Vari G; Silvani A; Pollo B; Garufi C; Ramponi S; Simonetti G; Ciusani E; Mandoj C; Scalera S; Villani V; Po A; Ferretti E; Regazzo G; Rizzo MG
J Exp Clin Cancer Res; 2023 Mar; 42(1):66. PubMed ID: 36932446
[TBL] [Abstract][Full Text] [Related]
10. Roles and Regulation of BCL-xL in Hematological Malignancies.
Morales-Martínez M; Vega MI
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216310
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.
Gennart I; Petit A; Wiggers L; Pejaković S; Dauchot N; Laurent S; Coupeau D; Muylkens B
Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34205549
[TBL] [Abstract][Full Text] [Related]
12. MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth.
Niu F; Dzikiewicz-Krawczyk A; Koerts J; de Jong D; Wijenberg L; Fernandez Hernandez M; Slezak-Prochazka I; Winkle M; Kooistra W; van der Sluis T; Rutgers B; Terpstra MM; Kok K; Kluiver J; van den Berg A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261009
[TBL] [Abstract][Full Text] [Related]
13. Targeting microRNA in hematologic malignancies.
Han Z; Rosen ST; Querfeld C
Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
[TBL] [Abstract][Full Text] [Related]
14. The relationship of miR-181a expression level and AML: A systematic review protocol.
Koolivand M; Moein S; MalekZadeh K
Int J Surg Protoc; 2019; 13():1-4. PubMed ID: 31851750
[TBL] [Abstract][Full Text] [Related]
15. Identification of a
Mariotti B; Calabretto G; Rossato M; Teramo A; Castellucci M; Barilà G; Leoncin M; Vicenzetto C; Facco M; Semenzato G; Bazzoni F; Zambello R
Haematologica; 2020 May; 105(5):1351-1360. PubMed ID: 31467122
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
17. The B Cell Activation-Induced miR-183 Cluster Plays a Minimal Role in Canonical Primary Humoral Responses.
Pucella JN; Cols M; Yen WF; Xu S; Chaudhuri J
J Immunol; 2019 Mar; 202(5):1383-1396. PubMed ID: 30683701
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Autoimmunity and Hematological Malignancies.
Di Marco M; Ramassone A; Pagotto S; Anastasiadou E; Veronese A; Visone R
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322050
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of
Deng Y; Li X; Feng J; Zhang X
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564
[TBL] [Abstract][Full Text] [Related]
20. Cell-to-cell communication: microRNAs as hormones.
Bayraktar R; Van Roosbroeck K; Calin GA
Mol Oncol; 2017 Dec; 11(12):1673-1686. PubMed ID: 29024380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
